Viewing Study NCT00975806


Ignite Creation Date: 2025-12-26 @ 1:18 PM
Ignite Modification Date: 2026-02-04 @ 12:55 PM
Study NCT ID: NCT00975806
Status: TERMINATED
Last Update Posted: 2019-11-25
First Post: 2009-09-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and Efficacy in Patients With Renal Cell Carcinoma
Sponsor: Celgene
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cell Carcinoma View
Keywords: